arlene siefker-radtke, esmo 2019 - keynote-866 phase iii trial in bladder cancer
Published 4 years ago • 136 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
1:03
one to watch: keynote-866, perioperative pembro with neoadjuvant chemo in mibc
-
0:45
prof. siefker-radtke on the ev-103 trial in bladder cancer
-
4:42
arlene siefker-radtke, md, regarding the development of erdafitinib in bladder cancer
-
1:59
arlene siefker-radtke, md, on how new data will impact treatment of neoadjuvant bladder cancer
-
15:10
2nd round of chemo (b cycle) - anaplastic large cell lymphoma (alcl) alk , kourtneystrong
-
11:29
enfortumab vedotin plus pembrolizumab: results of the ev-302 trial with thomas powles, md
-
24:35
esmo 2024: highlights and analysis
-
4:11
an overview of targeted fgfr3 therapy in bladder cancer with dr. siefker-radtke
-
8:55
andrea necchi, esmo 2019 - keynote-045 trial in advanced urothelial cancer
-
0:53
dr. siefker-radtke on fda approval of durvalumab in bladder cancer
-
1:51
dr. siefker-radtke on the treatment of fgfr-altered bladder cancer
-
4:52
current concepts in managing rare histologies in bladder cancer with dr. siefker-radtke
-
0:38
dr. siefker-radtke on fda approval of avelumab in bladder cancer
-
57:44
breakthroughs in bladder cancer: report from esmo-2023
-
1:09
comment: immunotherapy plus chemotherapy in bladder cancer
-
21:03
bladder cancer highlights from esmo 2022
-
6:39
rare and variant histologies in bladder cancer
-
0:57
dr. siefker-radtke on next steps with erdafitinib in bladder cancer
-
1:44
positive biomarkers to select patients for bladder preservation in bladder cancer
-
1:08
dr. arlene o. siefker-radtke on neoadjuvant chemotherapy plus surgery in bladder cancer